Eurofins Scientific has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Analytical Science Laboratories (ASL).
ASL is located in Kyoto and employs more than 140 staff. As part of this outsourcing program, Astellas has committed to provide ASL work covering its current capacity for an agreed period of time as the company invests in further capabilities and staff to serve a wider range of clients.
ASL will be Eurofins’ first laboratory in Japan offering test services with the Good Manufacturing Practice (GMP) standard. It will become a key laboratory for the Group’s global GMP laboratory network, counting already more than 30 GMP sites in Europe, India and the USA. This outsourcing deal with Astellas provides Eurofins with a valuable entry into the biopharmaceutical products testing market in Japan. The outsourcing of this highly reputed laboratory expands the Group’s growing footprint in Asia Pacific, and provides a good platform to further expand in the biopharmaceutical products testing market in Asia.
“We are very pleased that Astellas has entrusted Eurofins with its high quality internal laboratory, ASL. This is recognition of the high scientific and quality level of Eurofins’ network of GMP Biopharma product testing laboratories, said Dr. Gilles Martin, Eurofins CEO. “With ASL and our other GMP sites we are committed to providing Astellas and our expanding group of clients in the APAC region with continued unmatched high level of service. We look forward to welcoming ASL to Eurofins’ family of businesses. We are very excited to collaborate with Astellas Pharma Inc., one of the most innovative pharmaceutical companies in the world, and are eager to develop a long term mutually-beneficial relationship with them.”